Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: Xiying Shao Clear advanced filters
  • Soft electrostatic actuators are crucial for advancing robotic systems that require adaptability and safety in unstructured environments. This study introduces ultralight soft electrostatic actuators utilizing solid-liquid-gas architectures, achieving significant improvements in power-to-weight ratio and actuation speed, exemplified by a 60% increase in jump height in a jumping robot compared to traditional designs.

    • Hyeong-Joon Joo
    • Toshihiko Fukushima
    • Christoph Keplinger
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-13
  • HER2 targeted therapy combined with chemotherapy represents a standard approach for treating HER2-positive metastatic breast cancer (MBC). Here the authors report the results of a phase II trial of the small molecule tyrosine kinase inhibitor pyrotinib plus docetaxel as a first-line treatment for HER2-positive MBC.

    • Yabing Zheng
    • Wen-Ming Cao
    • Xiaojia Wang
    ResearchOpen Access
    Nature Communications
    Volume: 14, P: 1-9
  • CDK4/6 inhibition is a promising therapeutic approach to treat cancer, but it is challenged by resistance development. Here, the authors show that the RNA binding protein LRPPRC forms a positive feedback loop with CDK6 and inhibiting LRPPRC with the FDA-approved gossypol acetate overcomes CDK4/6 inhibition resistance.

    • Wei Zhou
    • Wenxi Wang
    • Xiaohong Fang
    ResearchOpen Access
    Nature Communications
    Volume: 14, P: 1-16